Trial Profile
Relapse rates and quality of life among patients receiving disease modifying therapy for multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary) ; Glatiramer acetate; Interferon
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 19 Feb 2016 New trial record